Institute of Biochemistry, Goethe University Frankfurt, Max-von-Laue-Str. 9, D-60438 Frankfurt Am Main, Germany.
Department of Physics, University of Cagliari, S.P. 8 Km 0.700, 09042 Monserrato (CA), Italy.
J Mol Biol. 2020 Feb 14;432(4):861-877. doi: 10.1016/j.jmb.2019.12.025. Epub 2019 Dec 25.
AcrAB(Z)-TolC is the main drug efflux transporter complex in Escherichia coli. The extrusion of various toxic compounds depends on several drug binding sites within the trimeric AcrB transporter. Membrane-localized carboxylated substrates, such as fusidic acid and hydrophobic β-lactams, access the pump via a groove between the transmembrane helices TM1 and TM2. In this article, the transport route from the initial TM1/TM2 groove binding site toward the deep binding pocket located in the periplasmic part has been addressed via molecular modeling studies followed by functional and structural characterization of several AcrB variants. We propose that membrane-embedded drugs bind initially to the TM1/TM2 groove, are oriented by the AcrB PN2 subdomain, and are subsequently transported via a PN2/PC1 interface pathway directly toward the deep binding pocket. Our work emphasizes the exploitation of multiple transport pathways by AcrB tuned to substrate physicochemical properties related to the polyspecificity of the pump.
AcrAB(Z)-TolC 是大肠杆菌中主要的药物外排转运体复合物。多种毒性化合物的排出依赖于三聚体 AcrB 转运体中的几个药物结合位点。膜定位的羧化底物,如夫西地酸和疏水性β-内酰胺类抗生素,通过跨膜螺旋 TM1 和 TM2 之间的凹槽进入泵。在本文中,通过分子建模研究解决了从初始 TM1/TM2 凹槽结合位点到位于周质部分的深结合口袋的运输途径,随后对几种 AcrB 变体进行了功能和结构表征。我们提出,膜嵌入药物最初与 TM1/TM2 凹槽结合,被 AcrB 的 PN2 亚结构域定向,随后通过 PN2/PC1 接口途径直接运输到深结合口袋。我们的工作强调了 AcrB 对与泵多特异性相关的底物物理化学性质的多种运输途径的利用。